Women's Health Session Slated for Biotech 2001 in Atlantic City

Apr 13, 2001, 01:00 ET from Biotechnology Council of New Jersey, Inc. from ,Pennsylvania Biotechnology

    TRENTON, N.J., April 13 /PRNewswire/ -- A groundbreaking session on
 Women's Health is slated for Biotech 2001: Opportunities in the Nation's
 Pharmaceutical Center, which will take place on April 23-24, 2001 at the
 Atlantic City Convention Center and the Atlantic City Sheraton.  The session
 will focus on issues, developments, and breakthroughs in women's health,
 focusing on biotechnology's contribution to the development of pharmaceutical
 products that will advance health care for women.  Biotech 2001 is presented
 by the Biotechnology Council of New Jersey (BCNJ) and the Pennsylvania
 Biotechnology Association (PABIOTECH).
     The Women's Health session, moderated by Kim Louth, CEO, of Equity
 Research Group, features prominent speakers Gerianne M. DiPiano, President and
 CEO, Femme Pharma, Inc. and Thomas Stagnaro, CEO, of Levotech, Inc.  The panel
 will explore the advancing world of women's health care.
     This year's Symposium also includes focus panels such as Gene Therapy and
 the Future of Medicine; The Genomics Revolution; Finding an International
 Pharmaceutical Partner; Capital Formation Outlook; and Overview of the
 Industry.  Other topics include innovation in clinical trials; financial
 disclosure; hiring and retaining critical scientists and executives; deal
 making; and a round-up of what's in the pipeline in research institutions in
 our respective states.
     Sponsors to date include Aventis Pharmaceuticals, Ballard Spahr Andrews &
 Ingersoll, Ben Franklin Technology Partners, Biotechnology Industry
 Organization, Brettler Financial Group, BTG International, Inc., Centocor,
 Inc., Cephalon, Inc., Dechert, Delsys Pharmaceutical Corporation, Ernst &
 Young, GlaxoSmithKline, Greater Philadelphia First, Government of Canada,
 Harkins Cunningham, Imperial Bank, Kirkpatrick & Lockhart LLP, Medarex, Inc.,
 Merck & Company, Morgan, Lewis & Bockius LLP, NEOSE Technologies, Inc.,
 New Jersey Economic Development Authority, Ortho Biotech, Inc., PECO Energy
 Company, Pennsylvania Department of Community and Economic Development,
 Pharmacia, Inc., Pittsburgh Technology Council, Pittsburgh Regional Alliance,
 Port of Technology - A Science Center Company, PSE&G, QED Technologies, Inc.,
 S.R. One, Limited, University of Pittsburgh, and Wyeth Ayerst Laboratories.
     For more information about the program or to register, contact Symposium
 Headquarters at 800-231-0022.  Program details can also be found at
 www.newjerseybiotech.org and www.pabiotech.org.
     The Biotechnology Council of New Jersey and the Pennsylvania Biotechnology
 Association represent the biotechnology communities in their respective
 states.  Through their education and advocacy efforts, both associations work
 to advance biotechnology in the region.
 
 

SOURCE Biotechnology Council of New Jersey, Inc.; Pennsylvania Biotechnology
    TRENTON, N.J., April 13 /PRNewswire/ -- A groundbreaking session on
 Women's Health is slated for Biotech 2001: Opportunities in the Nation's
 Pharmaceutical Center, which will take place on April 23-24, 2001 at the
 Atlantic City Convention Center and the Atlantic City Sheraton.  The session
 will focus on issues, developments, and breakthroughs in women's health,
 focusing on biotechnology's contribution to the development of pharmaceutical
 products that will advance health care for women.  Biotech 2001 is presented
 by the Biotechnology Council of New Jersey (BCNJ) and the Pennsylvania
 Biotechnology Association (PABIOTECH).
     The Women's Health session, moderated by Kim Louth, CEO, of Equity
 Research Group, features prominent speakers Gerianne M. DiPiano, President and
 CEO, Femme Pharma, Inc. and Thomas Stagnaro, CEO, of Levotech, Inc.  The panel
 will explore the advancing world of women's health care.
     This year's Symposium also includes focus panels such as Gene Therapy and
 the Future of Medicine; The Genomics Revolution; Finding an International
 Pharmaceutical Partner; Capital Formation Outlook; and Overview of the
 Industry.  Other topics include innovation in clinical trials; financial
 disclosure; hiring and retaining critical scientists and executives; deal
 making; and a round-up of what's in the pipeline in research institutions in
 our respective states.
     Sponsors to date include Aventis Pharmaceuticals, Ballard Spahr Andrews &
 Ingersoll, Ben Franklin Technology Partners, Biotechnology Industry
 Organization, Brettler Financial Group, BTG International, Inc., Centocor,
 Inc., Cephalon, Inc., Dechert, Delsys Pharmaceutical Corporation, Ernst &
 Young, GlaxoSmithKline, Greater Philadelphia First, Government of Canada,
 Harkins Cunningham, Imperial Bank, Kirkpatrick & Lockhart LLP, Medarex, Inc.,
 Merck & Company, Morgan, Lewis & Bockius LLP, NEOSE Technologies, Inc.,
 New Jersey Economic Development Authority, Ortho Biotech, Inc., PECO Energy
 Company, Pennsylvania Department of Community and Economic Development,
 Pharmacia, Inc., Pittsburgh Technology Council, Pittsburgh Regional Alliance,
 Port of Technology - A Science Center Company, PSE&G, QED Technologies, Inc.,
 S.R. One, Limited, University of Pittsburgh, and Wyeth Ayerst Laboratories.
     For more information about the program or to register, contact Symposium
 Headquarters at 800-231-0022.  Program details can also be found at
 www.newjerseybiotech.org and www.pabiotech.org.
     The Biotechnology Council of New Jersey and the Pennsylvania Biotechnology
 Association represent the biotechnology communities in their respective
 states.  Through their education and advocacy efforts, both associations work
 to advance biotechnology in the region.
 
 SOURCE  Biotechnology Council of New Jersey, Inc.; Pennsylvania Biotechnology